Cytokines: Accelerators and brakes in the pathogenesis of cerebral malaria

Trends in Immunology

Volumn 24, Issue 9, 2003, Pages 491-499

  Hunt, Nicholas H ^a   Grau, Georges E ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GAMMA INTERFERON; INTERLEUKIN 10; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ASTROCYTE; BIOCHEMISTRY; BRAIN MALARIA; BRAIN MICROCIRCULATION; CELLULAR DISTRIBUTION; CLINICAL FEATURE; ENDOTHELIUM; HUMAN; IMMUNOPATHOLOGY; LEUKOCYTE ADHERENCE; NONHUMAN; PATHOGENESIS; PLASMODIUM FALCIPARUM; REVIEW; TH1 CELL; THROMBOCYTE; UPREGULATION;

EID: 0041378119     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00229-1     Document Type: Review

References (83)

1. de Souza J.B., Riley E.M. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 4:2002;291-300.
2. Medana I.M., et al. Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia. 19:1997;91-103.
3. Medana I.M., et al. Tumor necrosis factor-α expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am. J. Pathol. 150:1997;1473-1486.
4. Medana I.M., et al. Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier. Glia. 16:1996;51-64.
5. Ma N.L., et al. Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia. 19:1997;135-151.
6. Medana I.M., et al. Central nervous system in cerebral malaria: 'innocent bystander' or active participant in the induction of immunopathology? Immunol. Cell Biol. 79:2001;101-120.
7. Schluesener H.J., et al. Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells. Acta Neuropathol. (Berl.). 96:1998;575-580.
8. Toro G., Roman G. Cerebral malaria. A disseminated vasculomyelinopathy. Arch. Neurol. 35:1978;271-275.
9. Medana I.M., et al. Axonal injury in cerebral malaria. Am. J. Pathol. 160:2002;655-666.
10. Grau G.E., et al. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 237:1987;1210-1212.
11. Thumwood C.M., et al. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology. 96:1988;579-589.
12. MacPherson G.G., et al. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119:1985;385-401.
13. Patnaik J.K., et al. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am. J. Trop. Med. Hyg. 51:1994;642-647.
14. Porta J., et al. Immunopathological changes in human cerebral malaria. Clin. Neuropathol. 12:1993;142-146.
15. Jennings V.M., et al. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect. Immun. 65:1997;4883-4887.
16. Grau G.E., et al. Platelet accumulation in brain microvessels in fatal paediatric cerebral malaria. J. Infect. Dis. 187:2003;461-466.
17. Mackenzie C.D., et al. Intravascular leucocytes in the brain in Malawian children with fatal malaria. Am. J. Trop. Med. Hyg. 61:1999;476.
18. Clark I.A., Rockett K.A. The cytokine theory of human cerebral malaria. Parasitol. Today. 10:1994;410-412.
19. Turner G.D.H., et al. An immunohistochemical study of the pathology of fatal malaria: evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am. J. Pathol. 145:1994;1057-1069.
20. Grau G.E., et al. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur. J. Immunol. 21:1991;2265-2267.
21. Lucas R., et al. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27:1997;1719-1725.
22. Favre N., et al. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1:1999;961-968.
23. Grau G.E., et al. TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur. Cytokine Netw. 4:1993;415-419.
24. Piguet P.F. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Infect. Immun. 68:2000;3822-3829.
25. Gerardin P., et al. Prognostic value of thrombocytopenia in African children with falciparum malaria. Am. J. Trop. Med. Hyg. 66:2002;686-691.
26. Yanez D.M., et al. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157:1996;1620-1624.
27. Amani V., et al. Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30:2000;1646-1655.
28. Hansen D.S., et al. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity. 18:2003;391-402.
29. Ho M., et al. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J. Infect. Dis. 172:1995;838-844.
30. Ringwald P., et al. Levels of cytokines in plasma during Plasmodium falciparum malaria attacks. J. Clin. Microbiol. 29:1991;2076-2078.
31. Goodier M.R., et al. Cytokine profiles for human V γ 9(+) T cells stimulated by Plasmodium falciparum. Parasite Immunol. 17:1995;413-423.
32. Hensmann M., Kwiatkowski D. Cellular basis of early cytokine response to Plasmodium falciparum. Infect. Immun. 69:2001;2364-2371.
33. Artavanis-Tsakonas K., Riley E.M. Innate immune response to malaria: rapid induction of IFN-γ from human NK cells by live Plasmodium falciparum-infected erythrocytes. J. Immunol. 169:2002;2956-2963.
34. Koch O., et al. IFNGR1 gene promoter polymorphisms, susceptibility to cerebral malaria. J. Infect. Dis. 185:2002;1684-1687.
35. Grau G.E., et al. Tumor necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112:1989;49-70.
36. Garcia I., et al. Transgenic mice expressing soluble TNF-R1-IgG3 molecules are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25:1995;2401-2407.
37. Rudin W., et al. Resistance to cerebral malaria in tumor necrosis factor-α/β-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am. J. Pathol. 150:1997;257-266.
38. Grau G.E., et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1989;1586-1591.
39. Kwiatkowski D., et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 336:1990;1201-1204.
40. Molyneux M.E., et al. Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. Cytokine. 5:1993;604-609.
41. Shaffer N., et al. Tumor necrosis factor and severe malaria. J. Infect. Dis. 163:1991;96-101.
42. Molyneux M.E. Tumour necrosis factor, interleukin-6, and malaria. Lancet. 337:1991;1098.
43. Kern P., et al. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J. Infect. Dis. 166:1992;930-934.
44. Stoelcker B., et al. Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria. Infect. Immun. 70:2002;5857-5859.
45. van Hensbroek M.B., et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J. Infect. Dis. 174:1996;1091-1097.
46. Kremsner P.G., et al. Pentoxifylline prevents murine cerebral malaria. J. Infect. Dis. 164:1991;605-608.
47. Di Perri G., et al. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J. Infect. Dis. 171:1995;1317-1322.
48. McGuire W., et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
49. May J., et al. Plasma interleukin-10: tumor necrosis factor (TNF) -α ratio is associated with TNF promoter variants and predicts malarial complications. J. Infect. Dis. 182:2000;1570-1573.
50. Ubalee R., et al. Strong association of a tumor necrosis factor-α promoter allele with cerebral malaria in Myanmar. Tissue Antigens. 58:2001;407-410.
51. Hananantachai H., et al. Lack of association of-308A/G TNFA promoter and 196R/M TNFR2 polymorphisms with disease severity in Thai adult malaria patients. Am. J. Med. Genet. 102:2001;391-392.
52. Clark I.A., et al. TNF and Plasmodium berghei ANKA-induced cerebral malaria. Immunol. Lett. 25:1990;195-198.
53. Brown H., et al. Cytokine expression in the brain in human cerebral malaria. J. Infect. Dis. 180:1999;1742-1746.
54. Karunaweera N.D., et al. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3200-3203.
55. Engwerda C.R., et al. Locally up-regulated lymphotoxin α, not systemic tumor necrosis factor α, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195:2002;1371-1377.
56. Browning J.L., et al. Characterization of lymphotoxin-α β complexes on the surface of mouse lymphocytes. J. Immunol. 159:1997;3288-3298.
57. Clark I.A., et al. Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice - implications for malarial pathology. Trans. R. Soc. Trop. Med. Hyg. 86:1992;602-607.
58. Ferrante A., et al. Production of tumor necrosis factor-α and factor-β by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasites. Infect. Immun. 58:1990;3996-4003.
59. Kossodo S., et al. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology. 91:1997;536-540.
60. Ho M., et al. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. J. Infect. Dis. 178:1998;520-525.
61. Day N.P., et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 180:1999;1288-1297.
62. Moore K.W., et al. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:2001;683-765.
63. Belnoue E., et al. On the pathogenic role of brain-sequestered αβ CD8(+) T cells in experimental cerebral malaria. J. Immunol. 169:2002;6369-6375.
64. Belnoue E., et al. CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood. 101:2003;4253-4259.
65. Potter S., et al. Fas and perforin contribute to the pathogenesis of murine cerebral malaria. Redox Rep. 4:1999;333-335.
66. Omer F.M., Riley E.M. Transforming growth factor β production is inversely correlated with severity of murine malaria infection. J. Exp. Med. 188:1998;39-48.
67. Bagot S., et al. Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc. Natl. Acad. Sci. U. S. A. 99:2002;9919-9923.
68. Brown H.C., et al. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology. 55:2000;104-111.
69. Deininger M.H., et al. Differential cellular accumulation of transforming growth factor-β1,-β2, and -β3 in brains of patients who died with cerebral malaria. J. Infect. Dis. 181:2000;2111-2115.
70. Sanni L.A., et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and non-cerebral malaria. Am. J. Pathol. 152:1998;611-619.
71. Ball H.J., et al. Isolating vessels from the mouse brain for gene expression analysis using laser capture microdissection. Brain Res. Brain Res. Protoc. 9:2002;206-213.
72. Dobbie M., et al. Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism? Am. J. Trop. Med. Hyg. 62:2000;284-290.
73. Medana, I.M. et al. Metabolites of the kynurenin pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J. Infect. Dis., (in press).
74. Medana I.M., et al. The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. J. Infect. Dis. 185:2002;650-655.
75. White N.J., et al. Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. Lancet. 1:1985;776-778.
76. Molyneux M.E., et al. Clinical features and prognostic indicators in paediatric cerebral malaria - a study of 131 comatose Malawian children. Q. J. Med. 71:1989;441-459.
77. Sanni L.A., et al. Is ischemia involved in the pathogenesis of murine cerebral malaria? Am. J. Pathol. 159:2001;1105-1112.
78. Chan-Ling T., et al. Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am. J. Pathol. 140:1992;1121-1130.
79. 1H-magnetic resonance spectroscopy-determined cerebral lactate and poor neurological outcomes in children with central nervous system disease. Ann. Neurol. 41:1997;470-481.
80. Yu N., et al. Tumor necrosis factor-a and interleukin-1 α enhance glucose utilization by astrocytes: involvement of phospholipase A2. Mol. Pharmacol. 48:1995;550-558.
81. Tureen J. Effect of recombinant human tumor necrosis factor-α on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: Role of nitric oxide. J. Clin. Invest. 95:1995;1086-1091.
82. Fink M.P. Bench-to-bedside review: cytopathic hypoxia. Crit. Care. 6:2002;491-499.
83. Medana I.M., et al. Cellular stress and injury responses in the brains of adult Vietnamese patients with fatal Plasmodium falciparum malaria. Neuropathol. Appl. Neurobiol. 27:2001;421-433.